Pages that link to "Q424247"
Jump to navigation
Jump to search
The following pages link to acute intermittent porphyria (Q424247):
Displayed 50 items.
- chlorpromazine (Q407972) (← links)
- Identification of the most common mutation within the porphobilinogen deaminase gene in Swedish patients with acute intermittent porphyria (Q24559969) (← links)
- Two different point G to A mutations in exon 10 of the porphobilinogen deaminase gene are responsible for acute intermittent porphyria (Q24618191) (← links)
- A point mutation G----A in exon 12 of the porphobilinogen deaminase gene results in exon skipping and is responsible for acute intermittent porphyria (Q24635350) (← links)
- High frequency of mutations in exon 10 of the porphobilinogen deaminase gene in patients with a CRIM-positive subtype of acute intermittent porphyria (Q24669946) (← links)
- Molecular heterogeneity of acute intermittent porphyria: identification of four additional mutations resulting in the CRIM-negative subtype of the disease (Q24678243) (← links)
- An update of clinical management of acute intermittent porphyria (Q26781152) (← links)
- Renal failure affects the enzymatic activities of the three first steps in hepatic heme biosynthesis in the acute intermittent porphyria mouse (Q27307650) (← links)
- Structural insight into acute intermittent porphyria (Q27652571) (← links)
- Structure of human porphobilinogen deaminase at 2.8 A: the molecular basis of acute intermittent porphyria (Q27653713) (← links)
- Non-erythroid form of acute intermittent porphyria caused by promoter and frameshift mutations distant from the coding sequence of exon 1 of the HMBS gene (Q28143387) (← links)
- Detection of seven point mutations in the porphobilinogen deaminase gene in patients with acute intermittent porphyria, by direct sequencing of in vitro amplified cDNA (Q28201759) (← links)
- Acute intermittent porphyria: a new hypothesis to explain Jean-Jacques Rousseau's urinary disorders (Q28202078) (← links)
- CRIM-positive mutations of acute intermittent porphyria in Finland (Q28207749) (← links)
- Homozygous acute intermittent porphyria in a 7-year-old boy with massive excretions of porphyrins and porphyrin precursors (Q28245781) (← links)
- Molecular diagnostics of acute intermittent porphyria (Q28247956) (← links)
- Acute intermittent porphyria caused by a C----T mutation that produces a stop codon in the porphobilinogen deaminase gene (Q28258211) (← links)
- Mutations in acute intermittent porphyria detected by ELISA measurement of porphobilinogen deaminase (Q28263415) (← links)
- May 2006 update in porphobilinogen deaminase gene polymorphisms and mutations causing acute intermittent porphyria: comparison with the situation in Slavic population (Q28288056) (← links)
- Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria (Q28305827) (← links)
- Molecular basis of acute intermittent porphyria: mutations and polymorphisms in the human hydroxymethylbilane synthase gene (Q28307580) (← links)
- Acute Intermittent Porphyria and Epilepsy: Safety of Clonazepam (Q28324495) (← links)
- Propranolol in acute intermittent porphyria (Q28328639) (← links)
- Acute Intermittent Porphyria: Clinical and Selected Research Aspects (Q28336947) (← links)
- Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait (Q28339673) (← links)
- Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients (Q28361210) (← links)
- The measurement of the synthetic rate of bilirubin from hepatic hemes in patients with acute intermittent porphyria (Q28364728) (← links)
- Psychotropic drugs in acute intermittent porphyria (Q30304316) (← links)
- De Novo mutation found in the porphobilinogen deaminase gene in Slovak acute intermittent porphyria patient: molecular biochemical study. (Q30359845) (← links)
- Acute intermittent porphyria, seizures, and antiepileptic drugs: a report on a 3-year-old Nigerian boy. (Q31953936) (← links)
- Coagulopathy Associated with Hematin Treatment for Acute Intermittent Porphyria (Q33486431) (← links)
- Antinuclear antibodies and the diagnosis of systemic lupus erythematosus in patients with acute intermittent porphyria (Q33562539) (← links)
- Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetase (Q33584824) (← links)
- Feline acute intermittent porphyria: a phenocopy masquerading as an erythropoietic porphyria due to dominant and recessive hydroxymethylbilane synthase mutations (Q33594209) (← links)
- Autonomic neuropathy in acute intermittent porphyria (Q33621548) (← links)
- Acute intermittent porphyria: mutation analysis and identification of gene carriers in a German kindred by PCR-DGGE analysis (Q33644337) (← links)
- Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities (Q33669659) (← links)
- Four mutations in the porphobilinogen deaminase gene in patients with acute intermittent porphyria (Q33682995) (← links)
- RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice (Q33694417) (← links)
- AAV8-mediated gene therapy prevents induced biochemical attacks of acute intermittent porphyria and improves neuromotor function (Q33730418) (← links)
- Treatment of immobilisation hypercalcaemia in acute intermittent porphyria: experience from three cases (Q33735766) (← links)
- Acute intermittent porphyria with seizure and paralysis in the puerperium. (Q33842931) (← links)
- Urine concentration of 3-ethyl-5-hydroxy-4,5-dimethyl-delta 3-pyrrolin-2-one ('mauve factor') is not causally related to schizophrenia or to acute intermittent porphyria (Q34057498) (← links)
- An analysis of six cases of acute intermittent porphyria (AIP). (Q34102321) (← links)
- Intensive care management of patients with acute intermittent porphyria: Clinical report of four cases and review of literature (Q34116275) (← links)
- Acute abdominal pain caused by acute intermittent porphyria - case report and review of the literature (Q34118734) (← links)
- Severe neurologic manifestations in acute intermittent porphyria developed after spine surgery under general anesthesia: a case report (Q34302422) (← links)
- Acute intermittent porphyria: studies of the severe homozygous dominant disease provides insights into the neurologic attacks in acute porphyrias (Q34366289) (← links)
- Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity (Q34397074) (← links)
- Genetic heterogeneity in acute intermittent porphyria: characterisation and frequency of porphobilinogen deaminase mutations in Finland (Q34486531) (← links)